190 related articles for article (PubMed ID: 29362613)
1. Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.
Atwa A; Hegazy R; Mohsen R; Yassin N; Kenawy S
Open Access Maced J Med Sci; 2017 Dec; 5(7):880-892. PubMed ID: 29362613
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats.
Atwa A; Hegazy R; Shaffie N; Yassin N; Kenawy S
Open Access Maced J Med Sci; 2016 Sep; 4(3):329-336. PubMed ID: 27703551
[TBL] [Abstract][Full Text] [Related]
3. Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways.
Refaie MMM; El-Hussieny M; Zenhom NM
Environ Toxicol Pharmacol; 2018 Mar; 58():212-219. PubMed ID: 29408764
[TBL] [Abstract][Full Text] [Related]
4. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
[TBL] [Abstract][Full Text] [Related]
6. Different effects of selective β1-adrenoceptor antagonists, nebivolol or atenolol in acetaminophen-induced hepatotoxicity of rats.
Rofaeil RR; Kamel MY; Abdelzaher WY
Fundam Clin Pharmacol; 2017 Apr; 31(2):165-173. PubMed ID: 27862262
[TBL] [Abstract][Full Text] [Related]
7. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
9. Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats.
Fayez AM; Zakaria S; Moustafa D
Biomed Pharmacother; 2018 Sep; 105():428-433. PubMed ID: 29879626
[TBL] [Abstract][Full Text] [Related]
10. Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways.
Das J; Ghosh J; Roy A; Sil PC
Toxicol Appl Pharmacol; 2012 Apr; 260(1):35-47. PubMed ID: 22310181
[TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
[TBL] [Abstract][Full Text] [Related]
12. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
Hu JJ; Wang H; Pan CW; Lin MX
Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of genistein on lipopolysaccharide/D-galactosamine- induced hepatic failure in mice.
Lin X; Zhang S; Huang R; Wei L; Liang C; Chen Y; Lv S; Liang S; Wu X; Huang Q
Biol Pharm Bull; 2014; 37(4):625-32. PubMed ID: 24818258
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats.
Wen T; Wu ZM; Liu Y; Tan YF; Ren F; Wu H
Toxicology; 2007 Jul; 237(1-3):184-193. PubMed ID: 17587481
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
17. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
18. Galangin Activates Nrf2 Signaling and Attenuates Oxidative Damage, Inflammation, and Apoptosis in a Rat Model of Cyclophosphamide-Induced Hepatotoxicity.
Aladaileh SH; Abukhalil MH; Saghir SAM; Hanieh H; Alfwuaires MA; Almaiman AA; Bin-Jumah M; Mahmoud AM
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387329
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice.
He Y; Xia Z; Yu D; Wang J; Jin L; Huang D; Ye X; Li X; Zhang B
Int Immunopharmacol; 2019 Mar; 68():171-178. PubMed ID: 30641432
[TBL] [Abstract][Full Text] [Related]
20. The hepatoprotective effects of Sedum sarmentosum extract and its isolated major constituent through Nrf2 activation and NF-κB inhibition.
Wang GW; Zhang XL; Wu QH; Jin YB; Ning CT; Wang R; Mao JX; Chen M
Phytomedicine; 2019 Feb; 53():263-273. PubMed ID: 30668406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
